课题基金 / 基金详情

Novel Approaches Against Emerging Antimicrobial Resistance

Novel Approaches Against Emerging Antimicrobial Resistance
对抗新出现的抗菌素耐药性的新方法
批准号:
10391767
负责人:
Thale Cross Jarvis
金额:
$1.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-02-01 至 2023-01-31

项目摘要

项目成果

Thale Cross Jarvis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Support is requested for a Keystone Symposia conference entitled Novel Approaches Against Emerging Antimicrobial Resistance, organized by Drs. Man-Wah Tan and Deborah T. Hung. The conference will be held in Banff, Alberta, Canada from February 13-16, 2022. It has become clear that infectious diseases are among the greatest threats to human health and global stability. Chief among these threats is the rise in antibiotic resistance, which endangers our ability to treat otherwise curable infections. The capacity to discover and develop novel agents to fill the pipeline as existing antibiotics are lost to increasing resistance has to date been limited. The goal of this Keystone Symposia conference is to present cutting-edge approaches to antibiotic discovery, including application of expanded chemical space, systems chemical biology, and artificial intelligence and novel strategies for treating resistant infection, including CRISPR, vaccines, antibodies, phages and conjugates. The promise, challenges, and development paths of these new approaches and strategies will be discussed in the context of lessons learned from prior antibiotic development programs, and new innovations in clinical and regulatory pathways. Additionally, this conference will be held jointly with “The Human Microbiome: Ecology and Evolution.” This pairing will help to facilitate exploration of the impact of antibiotics on the microbiome and the microbiome on antibiotic resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioenergetics in Health and Diseases
  • 批准号:
    10609120
  • 项目类别:
  • 资助金额:
    $1.74万
  • 财政年份:
    2023
  • 负责人:
    Thale Cross Jarvis
  • 依托单位:
Autophagy and Neurodegeneration: Mechanisms to Therapies
  • 批准号:
    10608666
  • 项目类别:
  • 资助金额:
    $1.5万
  • 财政年份:
    2023
  • 负责人:
    Thale Cross Jarvis
  • 依托单位:
Adipose Tissue: Energizing Good Fat
  • 批准号:
    10609127
  • 项目类别:
  • 资助金额:
    $2.02万
  • 财政年份:
    2023
  • 负责人:
    Thale Cross Jarvis
  • 依托单位:
Cancer Neoantigens, Vaccines and Viruses
  • 批准号:
    10233861
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    2022
  • 负责人:
    Thale Cross Jarvis
  • 依托单位:
海外基金